Why established systems and relationships matter
Get updates from the Cell Lines Blog delivered to your inbox.
Are ‘super donors’ the answer to sustainable growth for the allogeneic cell and gene therapy industry?
Why reliance on a small subset of donors could introduce risk for companies
An expert opinion on HLA matching relevance for allogeneic cell therapies
By Jamie Margolis, PhD, Senior Vice President of Donor Services, NMDP/Be The Match
A case study from the Standards Coordinating Body developed in partnership with Be The Match BioTherapies
Design a tailored logistics plan to deliver
Q&A with the Be The Match BioTherapies Collection Network Liaison team
Q&A with Abby McDonald, PhD, Solutions Development Supervisor